Eads & Heald Wealth Management Cuts Position in The Procter & Gamble Company (NYSE:PG)

Eads & Heald Wealth Management trimmed its position in shares of The Procter & Gamble Company (NYSE:PG) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,385 shares of the company’s stock after selling 157 shares during the period. Procter & Gamble comprises about 1.2% of Eads & Heald Wealth Management’s portfolio, making the stock its 26th biggest position. Eads & Heald Wealth Management’s holdings in Procter & Gamble were worth $2,401,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Emerald Advisors LLC lifted its position in shares of Procter & Gamble by 1.8% in the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after acquiring an additional 65 shares during the period. O Brien Wealth Partners LLC raised its holdings in shares of Procter & Gamble by 3.3% in the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after buying an additional 65 shares in the last quarter. KFA Private Wealth Group LLC raised its holdings in shares of Procter & Gamble by 2.2% in the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after buying an additional 67 shares in the last quarter. Chemistry Wealth Management LLC raised its holdings in shares of Procter & Gamble by 1.2% in the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after buying an additional 67 shares in the last quarter. Finally, Watchman Group Inc. boosted its position in Procter & Gamble by 0.4% in the 3rd quarter. Watchman Group Inc. now owns 18,052 shares of the company’s stock valued at $2,633,000 after buying an additional 68 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

NYSE:PG traded up $0.12 during trading hours on Monday, reaching $155.45. 5,753,652 shares of the company were exchanged, compared to its average volume of 6,864,547. The company has a market capitalization of $365.78 billion, a P/E ratio of 26.22, a P/E/G ratio of 3.18 and a beta of 0.44. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $163.14. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44. The business has a 50 day moving average of $159.32 and a 200 day moving average of $152.63.

Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. The firm had revenue of $21.44 billion for the quarter, compared to the consensus estimate of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.59 EPS. Research analysts forecast that The Procter & Gamble Company will post 6.45 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.59%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 62.98%.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent research reports. Wells Fargo & Company increased their price objective on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. The Goldman Sachs Group initiated coverage on Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price target on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Barclays boosted their price target on Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a report on Friday. Finally, StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $168.53.

Insider Buying and Selling

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 74,443 shares of the stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the completion of the sale, the chief executive officer now directly owns 973 shares in the company, valued at approximately $149,160.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Procter & Gamble news, insider Marc S. Pritchard sold 101,704 shares of Procter & Gamble stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the transaction, the insider now owns 163,428 shares in the company, valued at approximately $25,097,637.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Ma. Fatima Francisco sold 74,443 shares of Procter & Gamble stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total value of $11,412,111.90. Following the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $149,160.90. The disclosure for this sale can be found here. Insiders sold a total of 279,063 shares of company stock valued at $43,187,745 in the last three months. Insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.